Skip to content

Left Radial comparEd to Femoral Approach for CORonary Angiography in Patients With Previous CABG StuDy

Left Radial comparEd to Femoral Approach for CORonary Angiography in Patients With Previous CABG StuDy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03393052
Acronym
L-RECORD
Enrollment
150
Registered
2018-01-08
Start date
2017-01-20
Completion date
2018-05-15
Last updated
2018-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Vascular Access Complication

Keywords

L-RECORD, Radial, Femoral, CABG, coronary artery bypass graft

Brief summary

This randomized, multicenter, prospective study seeks to compare left radial and femoral access during cardiac catheterization of patients with prior history of CABG surgery, with the primary objective of demonstrating that the two access techniques do not differ in the net procedure time (non-inferiority study) expanding the documented benefits of radial access to this group of patients.

Detailed description

Patients from 4 different centers with a history of CABG are randomized 1:1 to left radial or femoral access. Based on the literature, a randomized study sample of a total of 150 patients was calculated with assumptions of 30 +/- 10-minute duration of the procedure, alpha = 5%, beta = 10% (power 90%) and non-inferiority limit Δ = 5 minutes. The primary endpoint of the study is the time it takes after placing the sheath at the initial puncture site until the completion of the diagnostic procedure (Net procedure time). Secondary endpoints include total time of the procedure, fluoroscopy time, total patient exposure radiation, amount of contrast used, possible vascular complications, major cardiovascular events and need for crossover access site.

Interventions

PROCEDURECoronary Angiography

Comparison of left radial versus femoral access during coronary angiography of patients who have undergone coronary artery bypass grafting surgery

Sponsors

Korgialenio-Benakio Red Cross Hospital
CollaboratorOTHER
University General Hospital of Heraklion
CollaboratorOTHER
AHEPA University Hospital
CollaboratorOTHER
University Hospital of Patras
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Age over 18 years 2. Written informed consent 3. Clinical indication for coronary angiography in a patient with prior history of CABG 4. Left radial artery has not been used as a graft during CABG

Exclusion criteria

1. Age over 90 years 2. Patient's refusal to participate in the study 3. Hemodynamic instability of the patient 4. Failure to place a sheath at the randomization access site 5. Arteriovenous fistula at the left upper limb 6. Use of right internal mammary artery as a graft during CABG 7. Creatinine clearance \<30 ml/min

Design outcomes

Primary

MeasureTime frameDescription
Net Procedure Time24 hoursThe time (min) after placement of the sheath at the initial puncture site until the completion of the diagnostic coronary angiography

Secondary

MeasureTime frameDescription
Fluoroscopy Time24 hoursRadiation time (min) after placing the sheath at the initial puncture site until the completion of the diagnostic coronary angiography
Dose Area Product24 hoursRadiation DAP (mGy\*cm2) during the diagnostic coronary angiography
Contrast Volume24 hoursContrast volume (ml) used during the diagnostic coronary angiography
Total Procedure Time24 hoursThe time (min) from local anesthesia at the access site until the completion of the diagnostic coronary angiography
Major Cardiovascular Events24 hoursDeath, stroke, acute myocardial infarction
Vascular Complications24 hoursVascular access complications
Crossover access site24 hoursNeed for crossover access site, other than this of randomization

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026